177Lu-PSMA-617 Consolidation Therapy After Docetaxel in Patients with Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Randomized, Phase 2 Trial.

Saved in:
Bibliographic Details
Title: 177Lu-PSMA-617 Consolidation Therapy After Docetaxel in Patients with Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Randomized, Phase 2 Trial.
Authors: Satapathy, Swayamjeet1 (AUTHOR), Das, Chandan K.2,3 (AUTHOR), Goyal, Shikha4 (AUTHOR), Sood, Ashwani1 (AUTHOR) sood99@yahoo.com, Periasamy, Kannan4,5 (AUTHOR), Aggarwal, Piyush1 (AUTHOR), Preet, Komal1 (AUTHOR), Singh, Shrawan K.6 (AUTHOR), Mavuduru, Ravimohan S.6 (AUTHOR), Bora, Girdhar S.6 (AUTHOR), Sharma, Aditya P.6 (AUTHOR), Prakash, Gaurav2 (AUTHOR), Kumar, Rajender1 (AUTHOR), Singh, Harmandeep1 (AUTHOR), Mittal, Bhagwant R.1 (AUTHOR)
Source: Journal of Nuclear Medicine. Jul2026, Vol. 67 Issue 7, p1068-1074. 7p.
Database: Engineering Source
Full text is not displayed to guests.
Description
ISSN:01615505
DOI:10.2967/jnumed.125.269913